ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,615.35
0.55%
US Tech 100
19,804.00
0.64%
Dow Jones
40,000.90
0.62%
Brent Oil
84.57
0.00%
Bitcoin
59,401.38
0.28%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. AcelRX Pharmaceuticals Inc (ACRX)

  7. AcelRX Pharmaceuticals Inc (ACRX) News

ACRX

AcelRX Pharmaceuticals (ACRX)

AcelRX Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ACRX
DateTimeSourceHeadlineSymbolCompany
09/06/20238:30AMPR Newswire (US)AcelRx Pharmaceuticals to Participate in the H.C. Wainwright Annual Investment ConferenceNASDAQ:ACRXAcelRX Pharmaceuticals Inc
08/28/20236:35AMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ACRXAcelRX Pharmaceuticals Inc
08/28/20236:34AMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ACRXAcelRX Pharmaceuticals Inc
08/25/20234:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACRXAcelRX Pharmaceuticals Inc
08/25/202312:45PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ACRXAcelRX Pharmaceuticals Inc
08/24/20234:23PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ACRXAcelRX Pharmaceuticals Inc
08/10/20235:00PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ACRXAcelRX Pharmaceuticals Inc
08/10/20234:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACRXAcelRX Pharmaceuticals Inc
08/10/20234:05PMPR Newswire (US)AcelRx Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:ACRXAcelRX Pharmaceuticals Inc
08/10/202312:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ACRXAcelRX Pharmaceuticals Inc
08/09/20235:29PMEdgar (US Regulatory)Form 424B7 - Prospectus [Rule 424(b)(7)]NASDAQ:ACRXAcelRX Pharmaceuticals Inc
08/02/20236:06AMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ACRXAcelRX Pharmaceuticals Inc
07/28/20232:07PMEdgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:ACRXAcelRX Pharmaceuticals Inc
07/27/20234:05PMPR Newswire (US)AcelRx to Host Second Quarter 2023 Financial Results Call and Webcast on August 10, 2023NASDAQ:ACRXAcelRX Pharmaceuticals Inc
07/21/20238:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACRXAcelRX Pharmaceuticals Inc
07/21/20238:00AMPR Newswire (US)AcelRx Pharmaceuticals Announces Closing of Previously Announced Private Placement Priced At-The-Market Under Nasdaq RulesNASDAQ:ACRXAcelRX Pharmaceuticals Inc
07/18/20238:00AMPR Newswire (US)AcelRx Pharmaceuticals Announces $10 Million Private Placement of Securities Priced At-The-Market Under Nasdaq RulesNASDAQ:ACRXAcelRX Pharmaceuticals Inc
06/15/20234:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
05/10/20234:12PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
05/10/20234:05PMPR Newswire (US)AcelRx Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:ACRXAcelRX Pharmaceuticals Inc
04/28/20234:08PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
04/27/20234:05PMPR Newswire (US)AcelRx to Host First Quarter 2023 Financial Results Call and Webcast on May 10, 2023NASDAQ:ACRXAcelRX Pharmaceuticals Inc
04/05/20238:30AMPR Newswire (US)AcelRx Pharmaceuticals Announces Closing of Divestment of DSUVIA® to Alora PharmaceuticalsNASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/30/20234:12PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/30/20234:05PMPR Newswire (US)AcelRx Pharmaceuticals Reports Full Year and Fourth Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/21/20234:05PMPR Newswire (US)AcelRx to Host Full Year and Fourth Quarter 2022 Financial Results Call and Webcast on March 30, 2023NASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/14/20238:30AMPR Newswire (US)AcelRx Pharmaceuticals Announces Divestment of DSUVIA® to Alora PharmaceuticalsNASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/06/20234:46PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/06/20234:44PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/06/20234:43PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ACRX

Your Recent History

TG
LYP2
Amundi S&P 500 II UCITS ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved